Category: Finance
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Janssen Licensing Cancer Antibodies in $1.8B Deal
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas.
-
Project to Catalog Precision Lung Cancer Immunotherapies
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer.
-
Personalized Computer Models Developed for Heart Disease
Researchers in the U.K. are developing computer models of heart functions that enable physicians to simulate recommended treatments for individual patients to gauge and optimize their outcomes.
-
3-D Printed Scaffolds with Stem Cells, Sensors Studied to Repair Bones
A bioengineering lab at University of Arizona is researching new techniques with three-dimensional printing, stem cells, and sensors to repair severe bone fractures.
-
NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center
A new federal grant supports expansion of a research and development center developing techniques to make the manufacture and integration of microfluidic, or lab-on-a-chip, devices easier and less expensive.
-
RNA Therapeutics Company Raises $30M in First Venture Round
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells.
-
NIH Funds Support for Point-of-Care Device Entrepreneurs
Two institutions in Massachusetts are starting a program to help inventors and new enterprises anywhere in the U.S. bring their point-of-care medical devices to market.
-
$200M Gift Supporting Translational Research, Start-Up Incubator
Harvard Medical School is the recipient of a gift from the Blavatnik Family Foundation to develop innovative treatments, apply advanced digital technologies, and accelerate biotech and life science start-up companies.
-
Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M
A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own.